title: Building an effective malaria vaccine pipeline to address global needs.
abstract: Despite impressive gains over the last 15 years in reducing the mortality associated with malaria, it remains a public health emergency. New interventions, such as vaccines, are needed to ensure that previous gains serve as a foundation for future progress. Vaccines have the potential to prevent severe disease and death in those most vulnerable, and to accelerate elimination and eradication by breaking the cycle of parasite transmission. The pipeline is as healthy as it has ever been, with approaches targeting different stages of the parasite lifecycle using an array of technologies. This article reviews recent progress and reviews key considerations in the quest to develop products that are aligned with the unmet medical need.
authors.affiliation: PATH Malaria Vaccine Initiative (MVI), 455 Massachusetts Avenue NW, Suite 1000, Washington, DC 20001-2621, USA. Electronic address: abirkett@path.org.
authors.forename: Ashley J
authors.initials: AJ
authors.lastname: Birkett
mesh_terms: D002986:Clinical Trials as Topic; D014943:Global Health; D006801:Humans; D008288:Malaria / Q000517:prevention & control*; D017780:Malaria Vaccines / Q000276:immunology
chemical_list: D017780:Malaria Vaccines